Zhu F - Search Results

1

Identification of the gene signature reflecting schizophrenia's etiology by constructing artificial intelligence-based method of enhanced reproducibility.

Yang QX, Wang YX, Li FC, Zhang S, Luo YC, Li Y, Tang J, Li B, Chen YZ, Xue WW, Zhu F. Yang QX, et al. Among authors: zhu f. CNS Neurosci Ther. 2019 Sep;25(9):1054-1063. doi: 10.1111/cns.13196. Epub 2019 Jul 27. CNS Neurosci Ther. 2019. PMID: 31350824 Free PMC article.

2

What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targets.

Zhu F, Han L, Zheng C, Xie B, Tammi MT, Yang S, Wei Y, Chen Y. Zhu F, et al. J Pharmacol Exp Ther. 2009 Jul;330(1):304-15. doi: 10.1124/jpet.108.149955. Epub 2009 Apr 8. J Pharmacol Exp Ther. 2009. PMID: 19357322

3

Update of TTD: Therapeutic Target Database.

Zhu F, Han B, Kumar P, Liu X, Ma X, Wei X, Huang L, Guo Y, Han L, Zheng C, Chen Y. Zhu F, et al. Nucleic Acids Res. 2010 Jan;38(Database issue):D787-91. doi: 10.1093/nar/gkp1014. Epub 2009 Nov 20. Nucleic Acids Res. 2010. PMID: 19933260 Free PMC article.

4

Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery.

Zhu F, Shi Z, Qin C, Tao L, Liu X, Xu F, Zhang L, Song Y, Liu X, Zhang J, Han B, Zhang P, Chen Y. Zhu F, et al. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36. doi: 10.1093/nar/gkr797. Epub 2011 Sep 24. Nucleic Acids Res. 2012. PMID: 21948793 Free PMC article.

5

Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study.

Xue W, Wang P, Li B, Li Y, Xu X, Yang F, Yao X, Chen YZ, Xu F, Zhu F. Xue W, et al. Among authors: zhu f. Phys Chem Chem Phys. 2016 Jan 28;18(4):3260-71. doi: 10.1039/c5cp05771j. Phys Chem Chem Phys. 2016. PMID: 26745505

6

Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study.

Zheng G, Xue W, Wang P, Yang F, Li B, Li X, Li Y, Yao X, Zhu F. Zheng G, et al. Among authors: zhu f. Sci Rep. 2016 May 27;6:26883. doi: 10.1038/srep26883. Sci Rep. 2016. PMID: 27230580 Free PMC article.

7

Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks.

Xu J, Wang P, Yang H, Zhou J, Li Y, Li X, Xue W, Yu C, Tian Y, Zhu F. Xu J, et al. Among authors: zhu f. Biomed Res Int. 2016;2016:2509385. doi: 10.1155/2016/2509385. Epub 2016 Jul 28. Biomed Res Int. 2016. PMID: 27547755 Free PMC article.

8

Performance Evaluation and Online Realization of Data-driven Normalization Methods Used in LC/MS based Untargeted Metabolomics Analysis.

Li B, Tang J, Yang Q, Cui X, Li S, Chen S, Cao Q, Xue W, Chen N, Zhu F. Li B, et al. Among authors: zhu f. Sci Rep. 2016 Dec 13;6:38881. doi: 10.1038/srep38881. Sci Rep. 2016. PMID: 27958387 Free PMC article.

9

NOREVA: normalization and evaluation of MS-based metabolomics data.

Li B, Tang J, Yang Q, Li S, Cui X, Li Y, Chen Y, Xue W, Li X, Zhu F. Li B, et al. Among authors: zhu f. Nucleic Acids Res. 2017 Jul 3;45(W1):W162-W170. doi: 10.1093/nar/gkx449. Nucleic Acids Res. 2017. PMID: 28525573 Free PMC article.

10

Differentiating Physicochemical Properties between Addictive and Nonaddictive ADHD Drugs Revealed by Molecular Dynamics Simulation Studies.

Wang P, Zhang X, Fu T, Li S, Li B, Xue W, Yao X, Chen Y, Zhu F. Wang P, et al. Among authors: zhu f. ACS Chem Neurosci. 2017 Jun 21;8(6):1416-1428. doi: 10.1021/acschemneuro.7b00173. Epub 2017 Jun 8. ACS Chem Neurosci. 2017. PMID: 28557437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,259 results

Search Page

Filters